Center for Financial Planning’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $487 | Hold |
10
| – | – | ﹤0.01% | 613 |
|
|
2025
Q1 | $341 | Hold |
10
| – | – | ﹤0.01% | 674 |
|
|
2024
Q4 | $394 | Hold |
10
| – | – | ﹤0.01% | 639 |
|
|
2024
Q3 | $470 | Hold |
10
| – | – | ﹤0.01% | 539 |
|
|
2024
Q2 | $541 | Hold |
10
| – | – | ﹤0.01% | 548 |
|
|
2024
Q1 | $682 | Hold |
10
| – | – | ﹤0.01% | 569 |
|
|
2023
Q4 | $626 | Hold |
10
| – | – | ﹤0.01% | 496 |
|
|
2023
Q3 | $454 | Hold |
10
| – | – | ﹤0.01% | 498 |
|
|
2023
Q2 | $562 | Hold |
10
| – | – | ﹤0.01% | 538 |
|
|
2023
Q1 | $453 | Hold |
10
| – | – | ﹤0.01% | 504 |
|
|
2022
Q4 | $406 | Hold |
10
| – | – | ﹤0.01% | 514 |
|
|
2022
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 586 |
|
|
2022
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 493 |
|
|
2022
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 494 |
|
|
2021
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 503 |
|
|
2021
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 468 |
|
|
2021
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 455 |
|
|
2021
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 504 |
|